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ABSTRACT  The actions of the optical enantiomers  of BAY K  8644 and Sandoz 
202  791  were  studied  on  barium  inward  currents  recorded  using  the  whole-ceU 
configuration  of the  patch  clamp  technique  from enzymatically  isolated  smooth 
muscle  cells  from  the  rabbit  ear  artery.  The  enantiomers  were  applied  by bath 
perfusion or rapidly by a concentration jump technique, which enabled the study of 
drug  action under  equilibrium  and  nonequilibrium  conditions.  A  larger effect of 
agonists was seen on peak inward current in  110 mMBa  when  small rather than 
large depolarizations were applied. The midpoint voltage of the steady-state inacti- 
vation curve of Iaa was --12.8 --  1.9 mV (n =  4) in the absence of drug,  -16.4 --- 2.5 
mV (n =  4) in 1 ~M (+)202 791, and -31.4 +_ 0.4 mV (n =  4) in  1 p.M (-)202  791. 
The rate  of onset of action of the  agonist and  antagonist  enantiomers  of BAY K 
8644 and Sandoz 202  791 was studied by rapid application during 20-ms depolar- 
izing steps from different holding potentials to +30 mV at  1 or 0.2 Hz. The drugs 
were applied as concentration jumps between two single pulses of a pulse train. The 
rates of onset of drug action on peak I~ during a  1-Hz pulse train were concentra- 
tion dependent over the range of 100 nM-3 v,M for both (+) and (-)202 791. The 
rate  of onset  of inhibition  of peak  current  by  antagonist  enantiomers  was  not 
significantly influenced by the test pulse frequency. At a  holding potential  of -60 
mV,  the onset rate  of the  increase  in peak IB~ on application  of 1 I~M of agonist 
enantiomers (+)202 791  or (-)BAY K 8644 during a train of pulses occurred with 
mean time constants of 2.1  -  0.7 s (n =  7) and 2.3 -+ 0.2 s (n =  4), respectively. The 
onset of current increase on application of 1 wM (+)202 791 during a single voltage 
clamp step to 20 mV was faster, with a mean time constant of 380  -  80 ms (n =  3). 
INTRODUCTION 
1,4-Dihydropyridine  (DHP)  compounds  interact  in  a  complex  way  with  calcium 
channels  in  various  tissues  (Triggle,  Skattebol,  Rampe,  Joslyn,  and  Gengo,  1986; 
Bechem,  Hebisch,  and  Schramm,  1988;  Glossmann  and  Striessnig,  1990).  The 
opposing actions  (agonist or antagonist)  of different  stereoisomers  of several DHPs 
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on calcium channels demonstrate a  highly specific mechanism of drug action (Hof, 
Ruegg, Hof, and Vogel,  1985),  which seems to reflect an interaction with the gating 
of L-type calcium channels (Hess, Lansman, and Tsien,  1984;  Kokubun, Prod'horn, 
Becker, Porzig, and Reuter,  1986;  Hering, Kleppisch, Timin, and Bodewei,  1989b; 
Lacerda and Brown, 1989; Marks and Jones, 1992).  There is general agreement that 
agonist  DHP  compounds  increase,  whereas  antagonist  DHPs  decrease  the  open 
probability of L-type calcium channels in heart (Hess et al.,  1984; Ochi, Hino, and 
Niimi, 1984),  smooth muscle (Yatani, Seidel, Allen, and Brown,  1987)  and neuronal 
calcium channels (Nowycky, Fox, and Tsien,  1985).  However,  agonist drug effects 
have been reported for several different "calcium antagonists" in studies of single 
calcium channels (Hess et al.,  1984)  as well as whole-cell calcium channel currents 
(Brown, Kunze, and Yatani,  1986;  Hering, Beech, and Bolton,  1987b;  Kass,  1987; 
Terada, Nakao, Okabe, Kitamura, and Kuriyama, 1987; Aaronson, Bolton, Lang, and 
MacKenzie, 1988). 
Agonist-DHP-induced gating of calcium channels was recently studied directly by 
means of a concentration jump technique. A rapidly occurring equilibration between 
the  applied  DHP  and  the  calcium channel receptor  in  such  experiments  can  be 
observed as a corresponding change in membrane conductance on application of the 
drugs  during single voltage clamp  steps  (Hering,  Beech,  Bolton,  and  Lim  1988; 
Hering et al.,  1989b;  Imaizumi, Muraki, Takeda, and Watanabe, 1989). 
The purpose of this study is to investigate the interaction of DHPs with the calcium 
channels in different states (C, O, and I) in isolated arterial smooth muscle cells. The 
voltage-dependent  effects  of  two  pairs  of  DHP  enantiomers  with  agonist  and 
antagonist  activity  (Sandoz  202  791  and  BAY  K  8644)  were  compared  under 
equilibrium  and  nonequilibrium  conditions.  Taking  advantage  of  the  less  pro- 
nounced  rundown  of  the  calcium  channel  current  in  isolated  ear  artery  cells 
compared with other  preparations  (see  Benham,  Hess,  and Tsien,  1987;  Hering, 
Bolton, Beech, and Lim, 1989a) and using the technique of rapid solution exchange 
(Hering et al.,  1987a), we were able to study for the first time the rate of action of 
agonist and antagonist DHPs in smooth muscle at different membrane potentials. 
METHODS 
Single smooth muscle cells were freshly dispersed  from rabbit  ear artery using a  modified 
procedure of Benham and Bolton (1986). Short segments (1-2 mm) of artery were incubated 
for 1 h in a modified physiological salt solution containing 10 ~M calcium, 2 mg/ml bovine 
serum albumin,  1 mg/ml collagenase (130 U/mg; Worthington Biochemical Corp., Freehold, 
NJ), 0.5  mg/ml papain  (15  U/mg;  Sigma  Immunochemicals,  St.  Louis,  MO), and  5  mM 
dithiothreitol, respectively. Cells were dispersed by mild agitation in this low-calcium  physiolog- 
ical salt solution. After centrifugation  the cells were resuspended in normal physiological salt 
solution containing (mM): 130 NaCl, 6 KCI, 1.7 CaCl~, 1.2 MgCl2, 14 glucose, and 10.7 HEPES 
buffered to pH 7.4 with NaOH. The cells were stored on coverslips at 4°C and used within 6-8 
h. The experiments  were performed using the whole-cell configuration  of the patch clamp 
technique  (Hamill, Marty, Neher,  Sakmann, and Sigworth, 1981) by means of a patch clamp 
amplifier (EPC-7; List-Electronic, Darmstadt, FRG). Patch pipettes had resistances of 3-5 MfL 
The internal (pipette) solution contained (mM): 126 NaCI, 3.2 MgSO4, 1 NaH2PO4, 2 EGTA, 
11.5 glucose,  2  Mg~ ATP, 10  TEA  and  5  HEPES buffered to  pH  7.2  with  NaOH.  The 
experiments  were carried  out in high-barium  solution containing (mM): 110 BaCI~ and  10 
HEPES buffered to pH 7.4 with TEA-OH. HERING ET AL.  Calcium  Channel Modulation by 1,4-Dihydropyridines  395 
A  BBC  microcomputer which  communicated with  a  1401 CED-programmable interface 
provided the voltage clamp command pulses through a  12-bit digital-to-analogue converter. 
Data were recorded on FM tape and later analyzed off-line after analogue-to-digital  conversion. 
The currents were low-pass filtered at 1 KHz with an 8-pole Butterworth filter (Barr and Stroud 
Inc., Glasgow,  UK).  Leak  currents were  subtracted either digitally using average values of 
steady leakage currents elicited by a 20-mV hyperpolarizing pulse or electronically by means of 
an analogue circuit. All recordings were made between 20 and 25°C. The current decay was 
fitted to an exponential function using the algorithm of Marquardt (1963).  Curve fitting of 
dose-response  data  was  performed  by  nonlinear regression  using  GraphPad  Inplot  3.0 
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F[GUI1E  1.  Effects  of the  agonist  (+)202  791  on  calcium channel currents  in  an  arterial 
smooth muscle cell from the rabbit ear artery. (A and B) Inward currents were recorded in 110 
mM extracellular BaCI~, stepping from a  holding potential of -60 mV to the indicated test 
potentials (TP) (10-mV steps).  (C and D) Currents of the same cell at the same test potentials in 
the presence of 1 ~M (+)202 791. Note the different current calibration inA and B vs. C and D. 
(GraphPad Software,  San Diego,  CA). The enantiomeric DHPs (+)-(S) 202  791  and (-)-(R) 
202  791  (is•pr•py•-4-(2•••3-benz•xadiaz••-4-y•)-•'4-dihydr•-2•6-dimethy•-5-nitr•-3•pyridine- 
carboxylate) (gifts from Sandoz AG, Basel, Switzerland) and (+) BAY K 8644 and (-) BAY K 
8644  (otherwise known as  BAY  R 4427  and BAY  K  5417;  gifts  from  Prof.  H.  Glossmann, 
Institut f~r Biochemische Pharmakologie, Innsbruck, Austria ) were applied by bath perfusion 
or by a concentration  jump technique previously described in detail (Hering et al.,  1987a). This 
enabled the application of the drugs within  < 10 ms (Hering et al.,  1987a,  1989a,  b). Stable 
whole-cell recordings were made from single cells in a micro-drop formed within an inner bath 
that was separated from an outer bath by a Sylgard polymer ring. The rapid application of new 
solution to the single cell from which recording was made took palce when solution (from the 396 
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FIGURE 2.  (A) The current-voltage relationship of peak inward currents in control 110  mM 
BaC12 (O) and after application (F-I)  of 1 v,M (+)202 791  (same experiment as Fig. 1). (B) The 
current-voltage relationship of peak inward currents in control 110  mM BaCI2 (O) and after 
application (n) of I  p,M (-)BAY K 8644. Currents were recorded from a holding potential of 
-60 mV. 
outer bath) flooded over the Sylgard ring and mixed with the micro-drop. Data are presented 
as mean values -+ SEM, 
RESULTS 
Action of the Enantiomers  of Sandoz 202  791 and BAY K 8644 under Equilibrium 
Conditions 
The  effects  of  the  optical  enantiomers  of  202  791  and  BAY  K  8644  on  the 
current-voltage relationship of the peak barium current were compared. The inward HERING ET AL.  Calcium Channel Modulation by 1,4-Dihydropyridines 
TABLE  I 
A  Comparison of the Effect of Agonist and Antagonist  Drugs on Peak Currents  (I~ 
Amplitude)  Evoked by 200-ms Pulses to  -10 or +40 mV from a HoMing Potential of 
-60 mV and Steady-State Inactivation  Parameters (1~ Availability) 
397 
IB= amplitude  lBa availability 
At-10mV  At +40mV  Vh  k  I. 
(% control)  (mV)  (mV)  (% peak) 
Control  100  100  -12.8 ±  1.9  8.5  ±  3.4  10.7 ±  0.1 
(+)202 791  433 ±  124  244 ±  19  -16.4 --- 2.5  6.7 --- 0.8  4.0 ±  3.0 
(-)BAY K 8644  472 ±  187  238 ±  31  --  --  -- 
(-)202 791  82 ±  6  37 ±  6  -31.4 ±  0.4  5.1  -  0.6  0 
(+)BAY K 8644  99 ±  13  45 ±  5  --  --  -- 
The values shown are means ±  SEM of three or four cells.  I wM of each drug was applied. 
currents were recorded before and after a 4-min equilibrium period with the drugs 
during the application of 200-ms pulses from a holding potential of -60 mV at 0.3 
Hz (Fig. 1). 
Both agonist compounds induced a concentration-dependent shift in the peak of 
the current-voltage relationship (Fig. 2, A and B). In the presence of 1 ~M (+)202 
791  the peak of the current-voltage relationship was shifted by 10  +-. 3 mV (n =  5) 
and  in  the  presence  of (-)BAY  K  8644  by  14  -+  2  mV  (n =  4)  in  the  negative 
direction. The drug-induced increase in peak current amplitude was much larger at 
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FIGURE  3.  Effect of antagonist DHP enantiomers on barium currents of rabbit ear artery cells. 
(A  and  B)  Inward currents  were  recorded  in  110  mM  extracellular  BaCI2  stepping  from  a 
holding potential of -60  mV to the indicated TP (10-mV steps). (C and D) Inward currents of 
the same cell in the presence of 0.1  wM (-)202  791. 398  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  101  •  1993 
small  depolarizations  compared  with  the  increase  in  current  at  voltages  near  the 
reversal  of the  current.  A  comparison  of the  increase  in  peak  current  values  at  test 
potentials  of -  10  and  +40  mV  is shown  in Table  I. 
Agonist  enantiomers  induced  an  increase  in  the  transient  component  of  the 
current.  On  application  of the  antagonist  (-)202  791  (0.I  p,M),  a  decrease  of the 
peak  current  was observed  which  was accompanied  by an  acceleration  in  the  current 
decay  (Fig.  3).  In  the  presence  of  1  ~M  (-)202  791  the  currents  now  inactivated 
almost  completely  during  a  200-ms  depolarizing  pulse.  The  inhibitory  effects  of 
TABLE  lI 
Equilibrium data  Data from on/off rates 
HP  - logEC~0  ECs0  - lOgKD  KD  Kof~  K_ t 
mV  M  nM  M  nM  s -I  s -t 
(+) 202 791 
-40  7.21  -+ 0.33  62  7.07 +  0.11  85  0.078 -+ 0.007 (n =  6)  0.1 
-60  6.89 +  0.10  128  7.13 +  0.19  74  0.076 +- 0.005 (n = 4)  -- 
-80  6.95 -  0.42  112  7.06 -4- 0.19  87  0.080 --I--  0.008 (n =  6)  -- 
(-) 202 791 
-40  6.97 -  0.03  110  6.60 ±  0.16  250  0.022 --. 0.005 (n =  3)  0.03 
-60  6.28 -  0.08  524  6.34 ~  0.05  457  0.016 -+ 0.004 (n =  6)  0.017 
-80  5.62 ±  0.38  2,400  5.87 --- 0.11  1,350  0.024 --. 0.005 (n =  3)  0.017 
Stimulation or inhibition of peak 1Ba by (+) or (-) 202 791,  respectively, were studied during 20-ms test 
pulse trains. The equilibrium data  -logECs0 (molar) were obtained from dose-response studies (pulses 
applied at a  frequency 0.3  Hz to minimize interaction with open or inactivated channels). The peak lsa 
inhibition or increase at steady state (i.e.,  after more than three onset time constants when the degree of 
change in peak I~ appeared to be stable) was fit to a  logistic expression: y  =  a+  (b -  a)/(l  +  (10x/10c), 
where a and b are the minimum and maximum of the curve, respectively (maximum constrained to 1 for no 
inhibition in the absence of drug), c =  IogECs0, and x = drug concentration assuming a pseudo Hill slope of 
-  1. The apparent KD values from on and off rates were calcualted from the kinetics of peak current changes 
on application of (+) or (-)202 791  during a  t-Hz pulse train according to Kon =  (I/'ron -  Ko~)/[x] with KD 
=  KoedK,~,,.  In  the calculation the  association rate  constant (Ko,),  %, was taken  to be  the  mean  of "ton 
measured at three concentrations of agonist and antagonist used (see Fig. 8, A and B). It should be noted, 
however, that %, for the agonist (+) 202  791  appeared not to be well described by a  model based on a 
simple bimolecular interaction which could introduce some error in our estimation of KD. The off rate of 
drug action (Ko~) was estimated from washout of(+) or (-) 202 791 during a 20-ms pulse (1 Hz) train to 30 
mV by concentration jump application of control solution between two pulses. Alternatively, the dissociation 
rate constant K-l was estimated from the intercept of the l/'r plot against drug concentration as described in 
Fig. 8. 
antagonist  enantiomers  were,  in  contrast  to  the  agonist  action,  less  pronounced 
during  small depolarizing  test pulses  (see Table  II;  cf.  Figs.  2, A  and  B  and  4, A  and 
B)  and  no  obvious  shift in  the  peak  of the  current-voltage  relationship  or activation 
curve was observed. 
Agonist  and  antagonist  enantiomers  of the  studied  DHPs  affected  the  steady-state 
inactivation  of  the  calcium  channel  to  different  extents.  The  calcium  channel 
availability  was  estimated  by measuring  the  peak  IBa  during  a  test pulse  to  +20  mV 
after  a  6-s conditioning  prepulse  with  an  interval  of 3  ms between  conditioning  and HERING ET AL. 
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FIGURE 4.  (A) The current-voltage relationships of peak inward currents in control  110 mM 
BaCI2 solution (O) and after application of 1 p~M (+) BAY K 8644 (El) currents were recorded 
from a  holding  potential  of -60  inV.  (B) The current-voltage relationship  of peak inward 
currents in control 110 mM BaCI, solution (O) and after cumulative application of 0.1  ~M (A) 
and  1 p~M (-)202 791  (I7) (same experiment as Fig. 3). 
test pulses. The data were fitted to the function: 
I/Ima x  -~-  (1  --  Iss)/{l  "4" EXP[(V- Vh)lk]} +  I,s 
where I/Imax is the normalized peak inward current evoked during the test pulse after 
a  6-s conditioning  pulse,  V is the conditioning  potential,  Vh is the voltage where 50% 
of  the  channels  are  available,  k  is  the  slope  parameter,  and  I,  is  a  sustained 
component of IBa that did not inactivate during the 6-s depolarizing  prepulse. 400  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  101  . 1993 
As shown in Fig. 5, A and B, the agonist enantiomers of both drugs induced small 
shifts in the midpoint voltage of the steady-state inactivation curve to more hyperpo- 
larized voltages.  In an additional  series  of experiments we studied  the dose depen- 
dency  of  the  shift  in  the  midpoint  voltage  of  the  availability  by  agonists  and 
antagonists  using a  pulse  protocol with  10-s prepulses.  Under  these  conditions  100 
nM,  300 nM,  and  1 ~M of the agonist  (+)202  791  induced  mean  shifts of 1.6,  6.8, 
and  10.5 mV (n =  3), respectively, in the hyperpolarizing direction. The correspond- 
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FIGURE 5.  Effect  of  agonist 
DHP enantiomers on the volt- 
age dependence of IBa availabil- 
ity. The peak currents during a 
200-ms  test  pulse  to  +20  mV 
were plotted versus the voltage 
of a 6-s conditioning prepuise. 
Interpulse  interval  was  3  ms. 
Solid lines are drawn according 
to the  equation I/Im~,  =  (1  -- 
Iss){1  +  exp[(V -  Vh)/k]}  +  lss- 
(A) Effect of (+)202 791 on the 
voltage dependence of Isa avail- 
ability.  Under  control  condi- 
tions  (O) l~x  =  87  pA,  Vh  = 
--14.5 mV,  k  =  11.2  mV,  and 
Is,  =  5  pA,  and  after  applica- 
tion of 1  o.M  (+)202  791  (.) 
/max  =  336 pA, V, =  -18.7 mV, 
k  =  6.7  mV, andI,s  =  12  pA, 
respectively.  (B)  Effect  of 
(-)BAY K 8644 on the voltage 
dependence  of 1B~  availability. 
Under  control  conditions  (O) 
/max  =  80 pA, Vh =  -17.8 mV, 
k  =  5.7 mV,  andl~  =  16 pA, 
and  after application  of 1 ~M 
(-) BAY K 8644 (I) Imax =  190 
pA,  Vh =  -19.3 mV, k  =  8.36 
mV,  and  I~,  =  15  pA,  respec- 
tively. 
ing shifts induced by  10 nM,  100 nM, and  1 I~M of (-)202  791  were 5.3,  10.3,  and 
17.7  mV  (n =  3),  respectively.  The  antagonist  enantiomers  shifted  the  inactivation 
curve by a substantial amount in the hyperpolarizing direction even on application of 
low drug concentrations that had little effect on the peak current value (Figs.  3  and 
6). The slowly inactivating component of the inward current was more affected by the 
antagonist enantiomers (Fig.  3) than by the agonist enantiomers  (Fig.  1). HERIN(; ET AL.  Calcium Channel Modulation by 1,4-Dihydropyridines  401 
Action of the Enantiomers of Sandoz 202 791 and BAY K 8644 under 
Nonequilibrium Conditions 
On  and  off rates  for drug  action  can  be  approximated  by  monitoring  of calcium 
channel currents and fast application of drug during the pulse train.  In a  biomolec- 
ular  binding  reaction,  the  rate  for  drug  binding  changes  with  concentration  in  a 
manner predicted by the law of mass action. The plot of l/'r against drug concentra- 
tion will give a straight line with a slope Kx and the intercept of the line with ordinate 
axis  is  K-I.  We  investigated  the  onset  rate  of action of the  agonist  and  antagonist 
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FIGURE 6.  (A)  Effect  of  the 
antagonist  (-)202  791  on  the 
voltage dependence oflh avail- 
ability.  For  the  control  (0) 
lm~ =  72 pA,  Vh =  -- 12.9 mV, 
k  =  9.7  mV,  I,  =  6  pA,  after 
application  (A)  of  0.1  IzM 
(-)202 791 Im~ =  42 pA, Vh = 
--29.4  mV,  k  =  6.6  mV,  and 
I, =  0 pA, and (.) after appli- 
cation  of  1  I~M  (-)202  791 
/max  =  31  pA, Vh =  -33.6 mV, 
k  =  5.8,  and  I,  =  0,  respec- 
tively.  (B)  Effect of (+)BAY  K 
8644  on  the  voltage  depen- 
dence of IBa availability.  Under 
control  conditions  (Q)  Ima~ = 
69pA, Vh =  -20.0 mV, k =  5.5 
mV  and  Iss  =  5pA  and  after 
application of 1 o.M (+)BAY K 
8644  (m) /max =  34  pA,  Vh  = 
--42.8  mV,  k  =  6.0  mV  and 
I, =  0 pA, respectively. 
compounds at different membrane potentials.  For this purpose the cell was depolar- 
ized from different holding potentials  at a  frequency of 1 Hz to a  potential  of +30 
mV by short (20 ms)  test pulses and the drug was applied  in a  concentration jump 
between  two successive test pulses of the pulse  train  (Fig.  7). The experiments were 
designed to minimize the amount of inactivation during a test pulse and to observe at 
the  same  time  the  rate  of onset of drug  action at a  negative  holding potential.  To 
exclude  possible  artifacts  of a  superimposed  rundown  of the  currents,  the  peak 
current amplitude of the inward current was monitored during a  1-Hz train of 20-ms 402  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  lOl  •  1993 
pulses  before each drug application.  Only cells with  stable  current amplitudes  over 
periods  of 2  min were used  in these  studies.  Fig.  7 A  shows the increase  in current 
amplitude  after a  concentration jump with  1 I~M (+)202 791  during an experiment 
where  the  test  pulses  were  applied  from  a  holding  potential  of -60  mV to  a  test 
potential of +30 mV. The increase in peak current amplitude on application of a  100 
times  lower concentration  of (+)202  791  (I0 nM)  is  shown in  Fig.  7  B.  (-)BAY K 
A  I  wM (+):O!  7el 
TIME (m):  1  8  6  7  8  9  10  11  12  13 
S  10 nM  (+)202 191 
100  pA 
'too ms 
TIME (s):  1  5  6  8  10  12  14  16  18  20 
300 
250 
200 
t50 
tO0 
-~  50 
0 
0 
T-  1.7e 
T-5.2s 
TIME AFTER DRUG APPLICATION (s) 
FIGURE 7.  Rate of onset of action of 
agonist  enantiomers  when  applied 
rapidly at negative membrane poten- 
tials during a train of brief pulses. (A) 
Increase  in  IBa  at  -60  mV  holding 
potential during a  1-Hz pulse train of 
20-ms test pulses  to  +30 mV after a 
concentration  jump  with  1  p,M 
(+)202  791.  Drug  application  be- 
tween  pulses  five  and  six  led  to  a 
rapid  increase  in  the  peak  current 
amplitude,  which  reached  a  steady- 
state value after  12  s.  Note the acceleration  in  the rate  of current decay but no detectable 
change  in  the  tail  current  kinetics  after  application  of the  agonist.  (B)  Increase  in  I~ on 
application  of  10  nM  (+)202  791.  Same  protocol  as  in  A.  (C)  Exponential  fits  to  the 
time-dependent increase in peak Isa on application of 1 p.M(+)202 701  (ll),  1 o.M (-)BAY K 
8644 (O), and  10 nM (+)202 791  (&). The estimated time constants are indicated in Fig. 8 B. 
8644  (1  IxM) was  also  tested  at  -60  mV;  its  onset  time  constant was  2.3  -  0.2  s 
(n =  4).  The  time  course  of  the  increase  in  peak  IBa  on  application  of agonist 
enantiomers during a pulse train could be fitted by a single exponential function (see 
Fig.  7  C). The mean time constants of the exponential  increase  in IBa when 1Ba was 
evoked  from  different  holding  potentials  are  given  in  Fig.  8  B.  As  shown,  the 
1/Xincr~ase plot at --60 and -80  mV can hardly be approximated by a linear regression 
line. For (-)202 791  (Fig. 8 A) those plots are indistinguishable for large hyperpolar- HERING ET AL  Calcium Channel Modulation by t,4-Dihydropyridines  403 
izations  (-80  and  -60  mV).  Faster onset of drug  action was  observed at  -40  mV 
holding potential. The  estimated values for Ko compared with  the values obtained 
from steady-state concentration-response relationships at various holding potentials 
are shown in Table II. There were no  significant differences in the unbinding rates 
for the agonist drug within a voltage range from  -80  to -40  mV. As shown in Table 
II,  the  off rates  (K-I) deduced  from  the  drug  onset  kinetics  (Fig.  8)  are  in  good 
agreement  with  the  drug  off rates  (Ko~)  estimated  by  rapid  washout  of drug  in 
concentration jump  experiments. To determine whether the action of the antagonist 
A 
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(+)  202  791  IN  ~M 
FIGURE 8.  Rate of development (on- 
set)  of antagonist  ((-)202  791)  and 
agonist ((+)202  791)  action at  -40, 
-60,  and  -80  mV  as  a  function  of 
applied drug concentration. Drug was 
applied in  concentration jumps dur- 
ing  a  train  of brief test  pulses.  (A) 
l/~blo~k of peak IBa inhibition at  -40 
(I-q), -60 (A), and -80 mV (O) hold- 
ing  potential  during  a  l-Hz  pulse 
train of 20-ms test pulses to +30 mV 
after application of 0.1,  1, and 3  I~M 
(-)202  791.  Estimated drug on rates 
are Kt[D] =  0.6 x  105 M -l s -~ at -40 
mV,  KI[D]  =  0.3  x  105  M -1  s -1  at 
-60 mV, and KI[D] =  0.3  x  105 M -1 
s -l at  -80 mV.  (B)  1/'rm  ..... of peak 
IB~ at --40 (ll), --60 (A), and -80 mV 
(0)  holding potential during a  1-Hz 
pulse  train  of  20-ms  test  pulses  to 
+30 mV; application of 0.01, 0.1, and 
1  I~M  (+)202  791.  Points  are  con- 
nected  by  lines;  linear  regression 
analysis  at  -40  mV  (I)  reveals 
KI[D] =  5  x  10  5 M -1 s -|. Data points 
in A and B represent mean values -+ 
SD  of  three  to  seven  experiments. 
The values for KI, which were estimated from the y-intercept of the linear regression lines, are 
shown in Table II. In most of the studied cells we could observe 80-90% recovery from drug 
action on rapid application of drug-free high-barium solution. 
was dependent on  the opening of the calcium channels, we tested the rate at which 
peak current was reduced on application of 2  tzM (-)202  791  during 20-ms pulses to 
+30 mV applied from a  holding potential of -50  mV at different pulse frequencies. 
In Fig. 9 A  drug was applied during a  1-Hz pulse train and in Fig. 9 B  the drug was 
applied 2 s after the last control current during a  0.2-Hz pulse train. Fig. 9 C displays 
the  time  course  of the  peak  current  inhibition  after  the  drug  application in  this 
experiment. The rates of onset of antagonism at the two pulse frequencies were very 
similar. 404  THE JOURNAL OF GENERAL PHYSIOLOGY • VOLUME 101  • 1993 
Currents evoked from a holding potential of -60  mV to a test potential of +20 mV 
displayed a  biphasic inactivation time course with a  fast inactivation time constant of 
156  +-- 49 ms and a  slow inactivation time constant of 5,250  -+ 2,709 ms (n =  4). The 
agonist enantiomer  (+)202  791  (1  IxM) was  applied during  the  slowly inactivating 
component of the inward current during a  6-s voltage jump  to  +20 mV (Fig.  10A). 
A  2  pM 02O2  781 
TIME (t):  1  5  e  7  8  9  10  16  20  25 
8  2  ~  (-)202  7e 1 
100 ms 
TIME (s):  1  5  10  15  20  25  30 
C 
100 
i  o,  ,  i  "i  =  ; 
0  5  I0  15  20 
TIME AFTER DRUG APPLICATION (s) 
FIGURE 9.  Rate of onset of action of 
(-)202  791  at a  holding potential of 
-50  mV.  (A)  2  ~M  (-)202  791  was 
applied between pulses five and six of 
a  1-Hz train of 20-ms pulses to  +30 
mV.  Currents  before and  at  selected 
time  intervals after drug  application 
are  shown  to  illustrate  the  gradual 
inhibition of the peak IBa. (B)  2  p.M 
(-)202 791  was applied by a concen- 
tration  jump  2  s  after  the  second 
pulse in a 0.2-Hz pulse train of 20-ms 
test pulses to  +30  mV.  Inward cur- 
rents at selected time intervals are displayed. (C) Time course of the inhibition of the inward 
current during a pulse train at -50 mV in two cells of  A and B stimulated at different rates (0.2 
and  1 Hz). The  rate of block is very similar, suggesting that brief activations of the inward 
current do not significantly affect the rate of block. 
The  increase  in  inward  current  produced  by  1  p~M  (+)202  791  is  shown  with  a 
monoexponential fit in Fig.  10 B. A mean time constant of 380  -  80 ms (n =  3) was 
estimated for the net increase in inward current on application of 1 p,M (+)202  791 
2-3 s after the voltage step to 20 mV during the slowly inactivating component oflBa 
(Fig. 10; see also Fig. 8 in Hering et al., 1989b). However, shortly after application of HERING  ET AL, 
A 
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I  pM (+)  202  791 
mv 
1 ~M(+)  202  701 
IkT-  0.22  s  I 
l  I 
(s) 
10 PA 
405 
FIGURE 10.  Application  of  (+)202 
791  at a  depolarized membrane po- 
tential The-barium current was acti- 
vated by a 6-s voltage steps from -60 
to +20 mV. (A) 1 wM (+)202 791 was 
applied by a  concentration jump 2 s 
after the voltage  jump (I). 2 shows the 
barium current at the second pulse in 
the presence of the drug after a rest 
period of 10 s at the holding potential 
of -60 mV. (B) The net increase in 
lh  is  shown.  This  was  obtained  by 
digital  subtraction of the control cur- 
rent decay during the previous pulse 
in the absence of (+)202 791 from the 
current  after  application  of  1  o.M 
(+)202  791.  The  activation  of  the 
agonist-induced current was fitted to 
a  monoexponential  function  and 
yielded a time constant of 220 ms. 
the  drug,  its effect on channel  kinetics  rapidly  reached  equilibrium,  and  thus  the 
amount of current at the end of the 6-s-depolarizing step when the drug was applied 
was 12 pA; it was 13 pA at the end of the next depolarizing pulse applied after a  10-s 
rest at  -60  mV in the presence of the drug (cf. Fig.  10A,  1  and 2).  The decay of 
current during the last 3 s of the pulse was virtually the same. This latter observation 
implies  that  the  rate  of channel  transitions  out  of or  into  the  open  state  may be 
unchanged. 
DISCUSSION 
In this study we observed a  pronounced similarity between the actions of the DHPs 
Sandoz 202 791  and BAY K 8644 on the calcium channel current in rabbit ear artery 
cells.  The  agonist  enantiomers  of both  drugs  induced  a  larger  increase  in  peak 
current during small than during large depolarizations, and also caused a shift in the 
peak of the current-voltage relationship and activation curve to more hyperpolarized 
voltages (see Figs.  1 and 2  and Table I). In contrast,  the antagonist enantiomers of 
both drugs were more potent during depolarizations to membrane potentials where 
the  channels  have  a  high  open  probability  and  undergo  inactivation.  A  smaller 
inhibitory effect on the peak current values of IBa was observed in the voltage range 
of -30  to  -10  mV (see  Figs.  3  and 4  and Table II). The agonist enantiomers,  in 
contrast, had less effect on the sustained component of the barium inward current. In 
this  respect  our results  confirm the  findings  of earlier  electrophysiological  studies 
where  similar changes  in  the  current-voltage  relationship  of the  calcium  channel 
current  caused by DHPs have been reported  for various tissues  (Hess et al.,  1984; 406  "f~AE JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  101  •  1993 
Sanguinetti,  Krafte, and  Kass,  1986;  Caffrey, Josephson,  and  Brown,  1986;  Bean, 
Sturek, Puga, and Hermsmeyer,  1986;  Markwardt and Nilius,  1988).  The observed 
dissimilar effects of agonist and antagonist DHPs under steady-state conditions (Figs 
1, 3, 5 and 6) may indicate selective binding of agonists to closed available or open 
channel conformations, while antagonists bind with a  higher affinity to inactivated 
(Bean,  1984;  Sanguinetti  and  Kass,  1984)  and/or  open  conformational states  of 
calcium channels or promote inactivation by accelerating the state transition rates to 
inactivated channel states (Hexing et al.,  1989b). 
Voltage-dependent Onset Rates for Agonist Action: Implications  for State-dependent 
Agonist DHP Binding 
Similar  agonist  concentrations  applied  at  different  membrane  potentials  induce 
different rates of current increase. The rate of increase of inward current on rapid 
application  of  1  ~M  (+)202  791  during  a  single  test  pulse  at  +20  mV  in  the 
concentration jump experiment in Fig.  10A  is  nearly monoexponential and faster 
than the current increase induced by a similar agonist concentration applied at more 
negative  membrane  potentials  during repetitive  application  of short  depolarizing 
pulses (Fig. 7). A slower onset of agonist action during weak compared with strong 
depolarizations  has  been  previously  shown  in  heart  cells  (Hering  et  al.,  1989b). 
Lacerda  and  Brown  (1989)  speculated  that  a  rate-limiting step  is  partitioning  of 
DHPs into the membrane. The observed difference in the time constants for agonist 
action at different membrane potentials suggests, however, that the accessibility of 
the receptor is not rate limiting. This finding is supported by recent findings of Kass, 
Arena, and Chin (1991), with evidence for an extracellular localization of the DHP 
receptor.  Different onset rates  of agonist action at different membrane  potentials 
may reflect state-dependent drug binding, i.e., a  higher affinity of agonist DHPs to 
open states. Alternatively, the observed differences in onset kinetics of drug action 
may  reflect  voltage  dependence  of  drug  association  and/or  dissociation,  or  a 
redistribution  of unbound  and  drug-bound  channels  between  different  channel 
states.  Hence, under nonsaturating drug concentrations there will be  a  mixture of 
both nonmodified and drug-modified channels. The former may have normal rate 
constants and the latter rate constants modulated by drug. Thus,  deviations of the 
association rate constants from a  simple bimolecular kinetics (Fig. 8 B) may reflect 
the  fact that  movement of channels  into  the  DHP-bound  state  depends  on  both 
concentration-dependent  and  concentration-independent  rate  constants.  At  high 
drug concentrations channel state transition rates might become rate limiting. Thus, 
in concentration jump experdments the onset picture could be camouflaged by the 
redistribution  of channels  between  states  of drug-bound  channels  with  modified 
gating.  In  other words,  monitoring of drug  onset by  peak  current  measurement 
during a train and subsequent interpretation of the data assuming simple bimolecu- 
lar kinetics may not always be adequate. 
Voltage-dependent Onset Rates for Antagonist Action: Implications  for 
State-dependent Antagonist DHP Binding 
These studies demonstrate that the affinity for the antagonist (-)202 791 is increased 
at  a  depolarized  membrane  potential  (-40  mV;  see Table  II and  Fig.  8).  These HERING L-r AL.  Calcium Channel Modulation by 1,4-Dihydropyridines  407 
findings are consistent with the hypothesis proposing that DHP antagonists possess 
high  affinity for  inactivated  states  of the  calcium  channel  (Bean,  1984).  Under 
conditions of microscopic reversibility, an increased affinity of drug for the inacti- 
vated state implies that the drug alters the transition rate of channels into or out of 
inactivated states,  since under these conditions binding rate constants and channel 
transition rates  are  interdependent.  However,  the  evidence  that  antagonists  bind 
selectively to inactivated (as opposed to open) states is not unequivocal. Hence, the 
inhibition of the sustained current component and faster apparent inactivation (see 
Lee  and  Tsien,  1983;  Gurney,  Nerbonne,  and  Lester,  1985),  but  also  increased 
potency at depolarized voltages can be  explained by open  channel block.  On  the 
other  hand,  an  additional  component  of block  for  drugs  with  high  affinity  to 
inactivated channel states would be expected in such a  case during high frequency 
depolarization. In this study the observed rates of antagonist-induced current decay 
at -50 mV were very similar during pulse trains of 0.2 and 1 Hz. Similar observations 
were made for other antagonist DHPs in smooth muscle (Terada et al. 1987; Hering 
et al.,  1988)  under different experimental conditions. This obvious discrepancy of 
1,4-DHP action in smooth muscle with the suggested similarity in 1,4-DHP action to 
the effect of local anesthetic on sodium channels could be explained by a very rapid 
unbinding of drug at negative holding potentials between the individual test pulses of 
a train. Various experimental findings do not, however, agree with such an assump- 
tion:  (a)  Hess,  Lansman,  and  Tsien  (1985)  have  shown  that  nitrendipine  and 
nimodipine do not affect the mean open time of calcium channels in ventricular cells 
but increase the percentage of null sweeps. Thus, if the drugs bind selectively to used 
channels (in the O  or I  state)  the channels remain blocked for several sweeps.  (b) 
Kinetic studies of drug action in whole-cell experiments also reveal slow unbinding 
rates of drug (rate constant of ~ 0.02 s-l; see Fig. 8 and Table II; see also results of 
Bean  [1984]  with  K-1  =  0.0012  s-l).  The  correlation  between  the  values  for 
unbinding of drug estimated in concentration jump experiments (Kofr)  and the values 
calculated with the y-intercept method (K-l; Fig. 8) indicates that the time constants 
observed in concentration jump experiments reflect binding and unbinding of drug 
to the DHP receptor. 
The  interpretation  of antagonist  DHPs  induced  changes  in  whole-cell  current 
kinetics (i.e.,  accelerated apparent inactivation time course; Fig.  3)  is also compli- 
cated by the  possibility that  the  transient component of current  decay is  at least 
partially determined by inactivation of T-type channels (Benham et al.,  1987).  The 
pronounced increase in the transient component of current in smooth muscle in the 
presence of agonist DHPs (Fig. 10; see also Bean et al., 1986)  suggests, however, that 
the  rapidly  decaying current  is  not entirely T-type  current  but  represents  a  fast 
kinetic component of L-type channels. It has been shown by Hering et al. (1988) that 
nifedipine  acts  very  slowly  in  smooth  muscle  cells when  applied  during  a  single 
voltage clamp step to depolarized voltages. In contrast in cardiac cells, (-)202  791 
(I  ~,M) acts fairly rapidly with an onset time constant of ~ =  200 ms (Hering et al., 
1989b).  It is unclear whether this difference is a pecularity of nifedipine or a general 
difference  between  calcium  channels  in  smooth  muscle  and  heart  cells.  Further 
studies will be necessary to resolve this question. Nevertheless, it is worth noting that 
the association kinetics of different DHPs vary considerably in radioligand binding 408  THE JOURNAL OF  GENERAL PHYSIOLOGY • VOLUME 101  • 1993 
studies with purified calcium channels even between two antagonist enantiomers of 
the  same  compound  (Knaus,  Striessnig,  Hering,  Marrer, Schwenner,  H61tje, and 
Glossmann,  1992). 
In conclusion, we believe that the kinetic analysis  of agonist and antagonist DHP 
action  in  concentration jump  experiments  has  great  potential  for revealing  new 
aspects of their state-dependent action and drug-induced changes in channel gating. 
This  approach  may  be  helpful  in  answering  a  number  of unresolved  questions 
regarding the interaction of DHPs with voltage-dependent calcium  channels, such as 
whether different compounds can be  distinguished  by  specific on and off rates  in 
electrophysiological experiments; whether DHPs act by binding to a single receptor 
site or multiple receptor sites (Kamp, Sanguinetti, and Miller,  1989; Hughes, Hering, 
and  Bolton,  1990;  Mironneau,  Yamamoto,  Sayet,  Arnaudeau,  Rakotoarisoa,  and 
Mironneau,  1992);  and whether differences exist between DHP action on voltage- 
dependent calcium channel in cardiac and smooth muscle. 
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